IFNG and Mendelian susceptibility to mycobacterial diseases: The first demonstration that genetic defects may contribute to severe mycobacterial infections in humans involved the identification of molecular defects in the IL-12/IFN-γ dependent signalling pathway in patients with Mendelian susceptibility to mycobacterial diseases (MSMD).